Author - Ziad

Productive Liaisons — Bringing Together Industry and Academia

Boston Harbor Angel members, Ziad Moukheiber and David Powsner, are the hosts of Failure – the Podcast, a podcast about about business failures, focusing on startups and emerging companies. In episode five, Moukheiber and Powsner chat with Randall Wright, program director of the MIT Industrial Liaison Program. Wright shares his unique view of creativity and innovation in business and research. Tune in >>
Read more...

New technology helps Odessa man with sight problems

A former Odessa High School student who is now attending college in Austin is not letting visual impairment get in his way. In fact, thanks to new technology Nick Flores' world has been opened up right before his eyes. Nick has optic nerve atrophy (ONA) which causes his vision to be distorted and affects depth perception. Fortunately Nick recently learned of a new device called eSIGHT, which has changed the way he sees everything. Read more >>  
Read more...

iCons Works at Fall Workshop

About 100 iCons scholars and applicants gathered in the Integrative Learning Center of UMass Amherst on Nov 9, 2017 for the annual iCons Fall Integrative Workshop. They came to hear Dr. Jonathan Thon tell the story of how his start-up company Platelet Biogenesis came to be. Integrated Concentration in Science (iCons) Program Director Justin Fermann introduced Thon to the crowd, telling the iCons students “we are here because we have work to do, and he’s got some problems we need...
Read more...

Boston Harbor Angels Awards Portfolio Companies at Annual Meeting

Boston Harbor Angels, one of the top three elite angels groups in the US, recognized three portfolio companies at its annual end-of-year general meeting. Exit of the Year Award: Corbus Pharmaceuticals on NASDAQ Biotech Startup of the Year Award: Astrocytes Pharmaceuticals Inc. IT Startup of the Year Award: Wasabi The meeting featured interviews with Yuval Cohen, CEO of Corbus Pharmaceuticals and Mark Tepper, President & Chief Scientific Officer of Corbus Pharmaceuticals; and David Friend, CEO and co-founder of Wasabi. The group also honored Mic Williams,...
Read more...

Boehringer Ingelheim highlights progress of immuno-oncology collaborations

In the last year, the firm has worked with the University of California at Los Angeles to develop a promising vaccine platform that can deliver a self-replicating RNA vaccine cargo to cancerous cells, helping the immune system to eliminate the cancer. It has also partnered with Siamab Therapeutics to identify anticancer therapeutics that target tumour-associated carbohydrate antigens, while another collaboration with AbeXXa Biologics has been formed to identify new selective molecular targets for cancer from the thousands of proteins found inside...
Read more...